Learn about the global parathyroid hormone market through The Business Research Company, which provides information on parathyroid hormone market size, parathyroid hormone market drivers and restraints, parathyroid hormone market players, the COVID-19 impact on the parathyroid hormone market, and more.

The global parathyroid hormone market size is expected to grow from $2.02 billion in 2021 to $2.15 billion in 2022 at a compound annual growth rate (CAGR) of 6.5%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The parathyroid hormone market is expected to reach $2.51 billion in 2026 at a CAGR of 4%.

The rise in the prevalence of osteoporosis is expected to drive the market for parathyroid hormones.

Request A Sample For The Global Parathyroid Hormone Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3427&type=smp

The parathyroid hormone market consists of sales of parathyroid hormones and related services by entities (organizations, sole traders and partnerships) that develop parathyroid hormones to treat various diseases. Parathyroid hormone is responsible for regulating the distribution of phosphate and calcium in the body, and is used in the treatment of diseases such as hypothyroidism and osteoporosis.

Global Parathyroid Hormone Market Segments Include:
By Disease Type: Hypocalcaemia, Hypoparathyroidism

By End-User: Hospitals, Clinics, Other

By Product Type: Recombinant Parathtyoid Hormone, Parathyroid Hormone Analogues

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America was the largest region in the parathyroid hormone market in 2021.

Companies in parathyroid hormones market are focusing on developing a biosimilar of parathyroid based drugs. A biosimilar is a biological product that is developed to be similar to an already FDA-approved biologic, known as the reference product. Biosimilars potentially offer consumers the opportunity to reduce their health care costs without compromising on treatment standards, thus parathyroid hormones manufacturing companies are investing in it.

TBRC’s parathyroid hormone market report covers:

Major Market Players: Pfizer Inc, Eli Lilly and Company, Radius Health Inc, Shire, Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc. and Gedeon Richter Plc.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2016-21) and ten years forecast (2022-2026-2031)

The Parathyroid Hormone Global Market Report 2022 –Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides parathyroid hormone market overviews, analyses and forecasts market size, share, parathyroid hormone market players, parathyroid hormone market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s parathyroid hormone market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here Is A List Of Similar Reports From The Business Research Company:

Anti-Thyroid Drugs Global Market Report 2021

Drugs For Hormonal Replacement Therapy Global Market Report 2021

Thyroid Cancer Drugs Global Market Report 2021

Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: